# Evaluation of Injectable Beta-tricalcium Phosphate Clinically in Treatment of Grade II Furcation Involvement

> **NCT04443972** · NA · COMPLETED · sponsor: **Hams Hamed Abdelrahman** · enrollment: 14 (actual)

## Conditions studied

- Furcation Defects

## Interventions

- **OTHER:** PD VitalOs cement®
- **OTHER:** Hydroxyapatite bone graft
- **OTHER:** biodegardable collagen membrane

## Key facts

- **NCT ID:** NCT04443972
- **Lead sponsor:** Hams Hamed Abdelrahman
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-12
- **Primary completion:** 2019-07-10
- **Final completion:** 2020-02-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04443972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04443972, "Evaluation of Injectable Beta-tricalcium Phosphate Clinically in Treatment of Grade II Furcation Involvement". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04443972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*